FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLots: 65680, BUD: 10/11/2022; 66043, BUD: 10/15/2022; 66372, BUD: 10/23/2022; 66597, BUD: 10/29/2022
Where it was soldAL, LA, MS, and TN
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forPharmacy Plus, Inc. dba Vital Care Compounder
Show the full FDA record
Full product labelSEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
Recalling firmPharmacy Plus, Inc. dba Vital Care Compounder
DistributionAL, LA, MS, and TN
Quantity800.5 mL in unit dose vials
Recall initiated2022-10-07
Report date2022-11-09
Recall completed—
Recall numberD-0053-2023
ClassificationClass II
FDA statusOngoing
Origin on fileHattiesburg MS United States

Related

Semaglutide recallsRecent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.